PhilipEvan PrestonJohnsonMD

PubMed

• Label-Free Solution-Based Kinetic Study of Aptamer-Small Molecule Interactions by Kinetic Capillary Electrophoresis with UV Detection Revealing How Kinetics Control Eq...
  Bao, J., Krylova, S.M., Reinstein, O., Johnson, P.E., Krylov, S.N.> ;Anal Chem. 2011 Nov 15
• Kinetic Capillary Electrophoresis with Mass-Spectrometry Detection (KCE-MS) Facilitates Label-Free Solution-Based Kinetic Analysis of Protein-Small Molecule Binding.
  Bao, J., Krylova, S.M., Wilson, D.J., Reinstein, O., Johnson, P.E., Krylov, S.N.> ;Chembiochem. 2011 Nov 25
• Engineering a Structure Switching Mechanism into a Steroid-Binding Aptamer and Hydrodynamic Analysis of the Ligand Binding Mechanism.
  Reinstein, O., Neves, M.D., Saad, M., Boodram, S.N., Lombardo, S., Beckham, S.A., Brouwer, J., Audette, G.F., Groves, P., Wilce, M.J., Johnson, P.E.> ;Biochemistry. 2011 Nov 1
• NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives.
  Zelenetz, A.D., Ahmed, I., Braud, E.L., Cross, J.D., Davenport-Ennis, N., Dickinson, B.D., Goldberg, S.E., Gottlieb, S., Johnson, P.E., Lyman, G.H., Markus, R., Matulo...> ;J Natl Compr Canc Netw. 2011 Sep
• Drug shortages: impact and strategies.
  Johnson, P.E.> ;J Natl Compr Canc Netw. 2011 Aug 1
• Identification of RNA-ligand interactions by affinity electrophoresis.
  Boodram, S.N., Cho, C.M., Tavares, T.J., Johnson, P.E.> ;Anal Biochem. 2011 Feb 1
• Finding the path in an RNA folding landscape.
  Boodram, S.N., Johnson, P.E.> ;Structure. 2010 Dec 8
• Defining a stem length-dependent binding mechanism for the cocaine-binding aptamer. A combined NMR and calorimetry study.
  Neves, M.D., Reinstein, O., Johnson, P.E.> ;Biochemistry. 2010 Oct 5
• Where are risk evaluation and mitigation strategies headed?
  Johnson, P.E.> ;Am J Health Syst Pharm. 2010 Sep 15
• NCCN oncology risk evaluation and mitigation strategies white paper: recommendations for stakeholders.
  > ;J Natl Compr Canc Netw. 2010 Sep
• NCCN Task Force Report: Specialty Pharmacy.
  Schwartz, R.N., Eng, K.J., Frieze, D.A., Gosselin, T.K., Griffith, N., Seung, A.H., Hinkel, J.M., Johnson, P.E., Johnson, S.A., Li, E.C., Szabatura, A.H., Wong, M.K.> ;J Natl Compr Canc Netw. 2010 Jul
• Structure of the cytosine-cytosine mismatch in the thymidylate synthase mRNA binding site and analysis of its interaction with the aminoglycoside paromomycin.
  Tavares, T.J., Beribisky, A.V., Johnson, P.E.> ;RNA. 2009 May
• Use and prescribing patterns for erythropoiesis-stimulating agents in inpatient and outpatient hospital settings.
  Siegel, J., Jorgenson, J., Johnson, P.E., Brophy, D.F., Comstock, T., Feng, A., Audhya, P.> ;Am J Health Syst Pharm. 2008 Sep 15
• Implications of biosimilars for the future.
  Johnson, P.E.> ;Am J Health Syst Pharm. 2008 Jul 15
• Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health care.
  Arbuckle, R.B., Griffith, N.L., Iacovelli, L.M., Johnson, P.E., Jorgenson, J.A., Kloth, D.D., Lucarelli, C.D., Muller, R.J.> ;Pharmacotherapy. 2008 May
• Current issues in pharmaceutical reimbursement.
  Fijalka, S., Fye, D., Johnson, P.E.> ;Am J Health Syst Pharm. 2008 Jan 15
• Introduction. Update on pharmaceutical reimbursement and implications for health-system pharmacists .
  Johnson, P.E.> ;Am J Health Syst Pharm. 2008 Jan 15
• Pharmaceutical reimbursement: an overview.
  Johnson, P.E.> ;Am J Health Syst Pharm. 2008 Jan 15
• The three-dimensional structure of the Moorella thermoacetica selenocysteine insertion sequence RNA hairpin and its interaction with the elongation factor SelB.
  Beribisky, A.V., Tavares, T.J., Amborski, A.N., Motamed, M., Johnson, A.E., Mark, T.L., Johnson, P.E.> ;RNA. 2007 Nov
• Patient assistance programs and patient advocacy foundations: alternatives for obtaining prescription medications when insurance fails.
  Johnson, P.E.> ;Am J Health Syst Pharm. 2006 Nov 1
• Changes in reimbursement rates and rules associated with the Medicare Prescription Drug Improvement and Modernization Act. Introduction.
  Johnson, P.E.> ;Am J Health Syst Pharm. 2006 Nov 1
• Medication use in schools.
  Johnson, P.E., Hayes, J.M.> ;Am J Health Syst Pharm. 2006 Jul 1
• RNA recognition by the Vts1p SAM domain.
  Johnson, P.E., Donaldson, L.W.> ;Nat Struct Mol Biol. 2006 Feb
• A low-starch barley mutant, risø 16, lacking the cytosolic small subunit of ADP-glucose pyrophosphorylase, reveals the importance of the cytosolic isofor...
  Johnson, P.E., Patron, N.J., Bottrill, A.R., Dinges, J.R., Fahy, B.F., Parker, M.L., Waite, D.N., Denyer, K.> ;Plant Physiol. 2003 Feb
• Characterization of the genes encoding the cytosolic and plastidial forms of ADP-glucose pyrophosphorylase in wheat endosperm.
  Burton, R.A., Johnson, P.E., Beckles, D.M., Fincher, G.B., Jenner, H.L., Naldrett, M.J., Denyer, K.> ;Plant Physiol. 2002 Nov
• Join now to see all